Table 3 Time around time for all PLHIV and those with unsuppressed HVL

1. TAT for all HVL tests

 a. Analytical TAT (date sample taken to date result entered into openMRS database), n = 12,512

  i. Processed in ≤ 14 days

3,342 (27%)

  ii. Overall, median (IQR)

27 days (14–61)

  iii. Sample processed at on-site laboratory, median (IQR)

21 days (13–39)

  iv. Sample processed at referral laboratory, median (IQR)

59 days (27–99)

 b. Overall TAT (date sample was taken to date participant received results (next clinical visit)), n = 8,385

  i. Overall, median (IQR)

91 days (36–94)

  ii. Sample processed at on-site laboratory, median (IQR)

91 days (33–93)

  iii. Sample processed at referral laboratory, median (IQR)

91 days (76–123)

2. TAT for PLHIV with unsuppressed HVL

 a. Analytical TAT, n = 494

  i. Processed in ≤ 14 days

93 (19%)

  ii. Overall, median (IQR)

49 days (20–88)

  iii. Sample processed at on-site laboratory, median (IQR)

17 days (8–31)

  iv. Sample processed at referral laboratory, median (IQR)

71 days (35–103)

 b. Overall TAT, n = 485

  i. Overall, median (IQR)

88 days (28–96)

  ii. Sample processed at on-site laboratory, median (IQR)

85 days (30–95)

  iii. Sample processed at referral laboratory, median (IQR)

91 days (74–118)

 c. Follow-up HVL TAT (date from unsuppressed HVL result entry into openMRS database to date of follow up HVL, n = 425

  i. Overall, median (IQR)

4.8 months (3.2–6.8)

  ii. Sample processed at on-site laboratory, median (IQR), n = 272

5.2 months (3.4–8.2)

  iii. Sample processed at referral laboratory, median (IQR), n = 153

3.9 months (3.2–5.8)